Association of MTHFR C677T (rs1801133) and A1298C (rs1801131) Polymorphisms with Serum Homocysteine, Folate and Vitamin B12 in Patients with Young Coronary Artery Disease

• Published in: Indian journal of clinical biochemistry Vol. 37; no. 2; pp. 224 - 231
• Main Authors: Shivkar, Rajni R., Gawade, Gayatri C., Padwal, Meghana K., Diwan, Arundhati G., Mahajan, Sumiran A., Kadam, Charushila Y.
• Format: Journal Article
• Language: English
• Published: New Delhi Springer India 01.04.2022; Springer Nature B.V
• Subjects: Biochemistry; Biomedical and Life Sciences; Cardiovascular disease; Cardiovascular diseases; Chemistry/Food Science; Coronary artery; Folic acid; Gene polymorphism; Genotyping; Heart diseases; Homocysteine; Hyperhomocysteinemia; Life Sciences; Methylenetetrahydrofolate reductase; Microbiology; Nutrient deficiency; Original; Original Research Article; Pathology; Patients; Polymorphism; Risk factors; Statistical analysis; Vitamin B; Vitamin B12; Young CAD; Homocysteine; Vitamin B12; Folate; MTHFR A1298C; MTHFR C677T
• ISSN: 0970-1915; 0974-0422
• DOI: 10.1007/s12291-021-00982-1

C677T (rs1801133) and A1298C (rs1801131) MTHFR gene polymorphisms and/or nutritional deficiency of folate/vitamin B12 leading to hyperhomocysteinemia is an established risk factor for CAD. The objective of this study was to evaluate the clinical usefulness of association between MTHFR C677T (rs1801133) and A1298C (rs1801131) polymorphisms with serum homocysteine, folate and vitamin B12 in addition to conventional cardiovascular risk factors in patients with young CAD. Genomic DNA was isolated from the whole blood. Genotyping of MTHFR C677T (rs1801133) and MTHFR A1298C (rs1801131) polymorphisms in young CAD patients and healthy controls was performed by ARMS-PCR method. Serum homocysteine, vitamin B12 and folate were estimated by CMIA and lipid profile parameters were measured by automated chemistry analyzers. Serum homocysteine levels were significantly higher but serum folate and vitamin B12 levels were not significantly different among young CAD group as compared to control group. Statistically significant hyperhomocysteinemia was observed in carriers of T allele for MTHFR 677C/T (rs1801133) genotype in young CAD group but this association was not significant for MTHFR 1298A/C (rs1801131) polymorphism. The association between hyperhomocysteinemia and CAD in young group was not independent of conventional cardiovascular risk factors. Risk of hyperhomocysteinemia and young CAD could be monitored by MTHFR polymorphism detection followed by serum homocysteine, folate and vitamin B12 measurements. The findings could help to prevent or delay the occurrence of young CAD through appropriate measures.